Does ROMOSOZUMAB-AQQG Cause Hepatic function abnormal? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Hepatic function abnormal have been filed in association with ROMOSOZUMAB-AQQG. This represents 0.2% of all adverse event reports for ROMOSOZUMAB-AQQG.
17
Reports of Hepatic function abnormal with ROMOSOZUMAB-AQQG
0.2%
of all ROMOSOZUMAB-AQQG reports
1
Deaths
11
Hospitalizations
How Dangerous Is Hepatic function abnormal From ROMOSOZUMAB-AQQG?
Of the 17 reports, 1 (5.9%) resulted in death, 11 (64.7%) required hospitalization, and 1 (5.9%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROMOSOZUMAB-AQQG. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does ROMOSOZUMAB-AQQG Cause?
Fall (646)
Fracture (612)
Arthralgia (517)
Injection site pain (490)
Bone density abnormal (454)
Off label use (419)
Hospitalisation (381)
Headache (360)
Product storage error (348)
Death (263)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which ROMOSOZUMAB-AQQG Alternatives Have Lower Hepatic function abnormal Risk?
ROMOSOZUMAB-AQQG vs ROPEGINTERFERON ALFA-2B-NJFT
ROMOSOZUMAB-AQQG vs ROPINIROLE
ROMOSOZUMAB-AQQG vs ROPIVACAINE
ROMOSOZUMAB-AQQG vs ROSIGLITAZONE
ROMOSOZUMAB-AQQG vs ROSUVASTATIN